China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Study of AI Combined with Remote Ultrasound to Improve the Stability Evaluatio... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study of Mitochondrial Genome Mutations in Postoperative Recurrence Monitori... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Investigation on Refractive Development and Eye Diseases of Children Aged 0-6 in Taiyua... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Effect Observation of Different Low Doses of Hydromorphone as Adjuvant Epidura... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction and verification of risk prediction model of device related pressure injur... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Establishment and early identification of risk factors for recurrence of haemorrhagic s... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase II, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Golixitinib... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of miRNAs methylation sequencing in patients with neovascular age-related macu... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Effect of Rosenthal Effect on Pain Catastrophizing and Pain Threshold in Patients w... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Open-Label, Multicenter Clinical Study of Intravenous Disitamab Vedotin ... Read More